← Back to Patent Explorer
US4382085A Expired / Lapsed US ⏱️ 0.0 years remaining

4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Assignee: Pfizer Inc
•
Filing: 1982-03-01
•
Granted: 1983-05-03
•
Expires: 2002-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 4''-Epi erythromycin A and 9-dihydro-4''-epi erythromycin A and derivatives thereof as useful antibacterial agents.

Inventors

  • 👤 Frank C. Sciavolino
  • 👤 Mark A. Guadliana

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 23:43
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08; A; A61; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 91 words
A compound selected from the group consisting of a macrolide antibiotic of the formula: ##STR4## and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of hydrogen, alkanoyl having from two to three carbon atoms and ethyl succinyl; R 1 and R 2 when considered separately are, respectively, hydroxy and hydrogen; R 1 and R 2 when considered together are an oxo group; R 3 and R 4 when considered separately are each hydrogen; and R 3 and R 4 when considered together are >C═O.
Claim 2
Dependent Claim 91 words
A compound selected from the group consisting of a macrolide antibiotic of the formula: ##STR4## and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of hydrogen, alkanoyl having from two to three carbon atoms and ethyl succinyl; R 1 and R 2 when considered separately are, respectively, hydroxy and hydrogen; R 1 and R 2 when considered together are an oxo group; R 3 and R 4 when considered separately are each hydrogen; and R 3 and R 4 when considered together are >C═O.
Claim 3
Dependent Claim 18 words
A compound of claim 1 wherein R 1 and R 2 when considered together are an oxo group.
Claim 4
Dependent Claim 18 words
The compound of claim 2 wherein R is hydrogen and R 3 and R 4 are each hydrogen.
Claim 5
Dependent Claim 18 words
The compound of claim 2 wherein R is acetyl and R 3 and R 4 are each hydrogen.
Claim 6
Dependent Claim 18 words
The compound of claim 2 wherein R is hydrogen and R 3 and R 4 together are >C═O.
Claim 7
Dependent Claim 18 words
The compound of claim 2 wherein R is acetyl and R 3 and R 4 together are >C═O.
Claim 8
Dependent Claim 23 words
A compound of claim 1 wherein R 1 is hydroxy, R 2 is hydrogen and R 3 and R 4 together are >C═C.
Claim 9
Dependent Claim 9 words
The compound of claim 7 wherein R is hydrogen.
Claim 10
Dependent Claim 9 words
The compound of claim 7 wherein R is acetyl.
Claim 11
Dependent Claim 23 words
A compound of claim 1 wherein R 1 is hydroxy, R 2 is hydrogen and R 3 and R 4 are each hydrogen.
Claim 12
Dependent Claim 9 words
The compound of claim 10 wherein R is hydrogen.
Claim 13
Dependent Claim 9 words
The compound of claim 10 wherein R is acetyl.
Claim 14
Dependent Claim 29 words
An antibacterial pharmaceutical composition comprising from about 0.5 to about 90 percent by weight of the total composition a compound as claimed in claim 1 and a pharmaceutical carrier.

References Cited (Backward Citations)

US3417077A Cited
US3884903A Cited
US4150220A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-05-02 1986-11-01 1987-05-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-05-02 1990-11-01 1991-05-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-05-02 1994-11-01 1995-05-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag